ANI Pharmaceuticals
ANIP
ANIP
186 hedge funds and large institutions have $766M invested in ANI Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 73 increasing their positions, 51 reducing their positions, and 16 closing their positions.
Holders
186
Holders Change
+14
Holders Change %
+8.14%
% of All Funds
2.97%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
30
Increased
73
Reduced
51
Closed
16
Calls
$1.65M
Puts
$1.96M
Net Calls
-$302K
Net Calls Change
-$560K
Top Buyers
1 |
1
BlackRock
New York
|
$145M |
2 |
2
Invesco
Atlanta,
Georgia
|
$19.7M |
3 |
3
Nuveen Asset Management
Chicago,
Illinois
|
$12.9M |
4 |
4
Charles Schwab
San Francisco,
California
|
$8.53M |
5 |
5
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$5.79M |